Back to top
Sekhon M, van der Straten A; MTN-041/MAMMA Study Team. Pregnant and breastfeeding women's prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability. PLoS One 2021 Nov 16;16(11):e0259779.
Jacobson C, Moodley J, Bhoola A, Sakwa R, Moodley J, Sukdao J, Hurbans N, Maharaj B, Naidoo A, Maclachlan M, Chareka G, Hlahla K, Chadza M; MTN-020/ASPIRE Study Team. Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial. Contemp Clin Trials Commun 2021 Nov 12;24:100859. PMCID: PMC8605196
Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET; MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS Behav 2021 Nov 2. Epub ahead of print
Parikh UM, Penrose KJ, Heaps AL, Halvas EK, Goetz BJ, Gordon KC, Hardesty R, Sethi R, Schwarzmann W, Szydlo DW, Husnik MJ, Chandran U, Palanee-Phillips T, Baeten JM, Mellors JW; MTN-020 Study Team. HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. J Int AIDS Soc 2021 Nov;24(11):e25833.
Roberts ST, Hawley I, Luecke E, Mensch B, Wagner T, Hoesley C, McClure T, Dominguez Islas CP, Piper JM, Liu AY, van der Straten A. Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial. J Womens Health (Larchmt) 2021 Oct 19. Epub ahead of print
Bauermeister JA, Tingler RC, Dominguez C, Dunne EF, Hoesley C, Ho K, Johnson S, Lucas J, Macagna N, Brown E, Gundacker H, Peda M, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Ayudhya RPKN, Marzinke MA, Piper J, Devlin B, Nuttall J, McGowan I, Hendrix CW, Cranston RD; MTN 026 team. Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS Behav 2021 Oct 17. Epub ahead of print
Ridgeway K, Montgomery ET, Smith K, Torjesen K, Straten AV, Achilles SL, Griffin JB. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception 2021 Oct 10:S0010-7824(21)00410-8. Epub ahead of print
Bauermeister JA, Tingler RC, Johnson S, Macagna N, Lucas J, Dominguez-Islas C, Szydlo D, Ngo J, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Kunjara Na Ayudhya RP, Piper J, Devlin B, Hendrix CW, Ho K; MTN-033 Protocol Team. Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study). AIDS Educ Prev 2021 Oct;33(5):361-376.
Nakalega R, Akello C, Gati B, Nakabiito C, Nolan M, Kamira B, Etima J, Nakyanzi T, Kemigisha D, Nanziri SC, Nanyonga S, Nambusi MJ, Mulumba E, Biira F, Nabunya HK, Akasiima SA, Nansimbe J, Maena J, Babirye JA, Ngure K, Mujugira A. Ethical considerations for involving adolescents in biomedical HIV prevention research. BMC Med Ethics 2021 Sep 23;22(1):127. PMCID: PMC8461968
Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. AIDS Behav 2021 Sep 21. Epub ahead of print
McGowan IM, Kunjara Na Ayudhya RP, Brand RM, Marzinke MA, Hendrix CW, Johnson S, Piper J, Holtz TH, Curlin ME, Chitwarakorn A, Raengsakulrach B, Doncel G, Schwartz Icloud Com J, Rooney JF, Cranston RD. An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate. AIDS Res Hum Retroviruses 2021 Sep 20. Epub ahead of print
Cranston RD, Brown E, Bauermeister J, Dunne EF, Hoesley C, Ho K, Johnson S, Lucas J, Dominguez-Islas C, Gundacker H, Peda M, Jacobson CE, Kramzer L, Singh D, Dezzutti CS, Kunjara Na Ayudhya RP, Brand RM, Wang L, Marzinke MA, Piper J, Devlin B, Nuttall J, McGowan I, Hendrix CW. A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS Res Hum Retroviruses 2021 Sep 9. Epub ahead of print
Husnik MJ, Brown ER, Dadabhai SS, Gaffoor Z, Jeenarain N, Kiweewa FM, Livant E, Mansoor LE, Mirembe BG, Palanee-Phillips T, Singh D, Siva S, Soto-Torres L, van der Straten A, Baeten JM; M. T. N.-020/ASPIRE Study Team. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS Behav 2021 Sep;25(9):2801-2814. PMCID:PMC8577988
Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, Singh D, Bunge KE, Naidoo L, Makanani B, Jeenarain N, Reynolds D, Hillier SL, Brown ER, Baeten JM, Balkus JE, MTN-020/ASPIRE study team. Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis 2021 Aug 2;73(3):513-520. PMCID: PMC8326546.
Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, Seyama L, Woeber K, Harkoo I, Reddy K, Tembo T, Mutero P, Tauya T, Chitukuta M, Gati Mirembe B, Soto-Torres L, Brown ER, Baeten JM, van der Straten A; MTN-020/ASPIRE study team. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav 2021 Aug;25(8):2430-2440. PMCID: PMC8222015
Noguchi LM, Marrazzo JM, Richardson B, Hillier SL, Balkus JE, Palanee-Phillips T, Nair G, Panchia R, Piper J, Gomez K, Ramjee G and Chirenje ZM. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa. Front Reprod Health 2021; 3:668685.
Baker Z, Javanbacht M, Moore J, Brosnan H, Squires K, Bunge K, Zimet G, Mensch B, Soto-Torres L, Kapogiannis B, Levy L, Hoesley C, Reirden D, Gaur A, Mayer K, Futterman D, Gorbach P. A qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls. J Acquir Immune Defic Syndr 2021 Jul 1;87(3):944-950. PMCID: PMC8192420
Katz AWK, Mansoor LE, Tsidya M, Mathebula F, Singh D, Siva S, Akello C, Chitowa TH, Garcia M, Soto-Torres L, Montgomery ET. Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2021 Jun 28. Epub ahead of print
Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, Taljaard M, Panchia R, Baeten JM, Balkus JE, Hladik F, Celum CL, Barnabas RV. Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization. AIDS 2021 Jun 24. Epub ahead of print
Liu AY, Dominguez Islas C, Gundacker H, Neradilek B, Hoesley C, van der Straten A, Hendrix CW, Beamer M, Jacobson CE, McClure T, Harrell T, Bunge K, Devlin B, Nuttall J, Spence P, Steytler J, Piper JM, Marzinke MA; MTN-036/IPM 047 Protocol Team for the Microbicide Trials Network. Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. J Int AIDS Soc 2021 Jun;24(6):e25747. PMCID: PMC8196716
Rael CT, Roberts S, Ibitoye M, Gorbach PM, Palanee-Phillips T, Harkoo I, Mbilizi Y, Panchia R, Siva S, Tembo T, Agwau Akello C, Balkus J, Riddler S, Carballo-Diéguez A. Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan Africa. Int J STD AIDS 2021 Jun;32(7):620-628. PMCID: PMC8594455
Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav 2021 Jun;25(6):1890-1900. PMCID: PMC8516082
Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A; MTN-025/HOPE Study Team. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. AIDS Behav 2021 May 19. Epub ahead of print
Stoner MCD, Brown ER, Palanee-Phillips T, Mansoor LE, Tembo T, Nair G, Akello C, Seyama L, Jeenarain N, Naidoo L, Mgodi N, Hunidzarira P, Chitukuta M, van der Straten A; MTN-020 ASPIRE and M-025 HOPE study teams. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence. AIDS Behav 2021 May 3. Epub ahead of print. PMCID: PMC8563504
Naidoo S, Duby Z, Hartmann M, Musara P, Etima J, Woeber K, Mensch BS, van der Straten A, Montgomery ET. Application of a Body Map Tool to Enhance Discussion of Sexual Behavior in Women in South Africa, Uganda, and Zimbabwe. Field methods 2021 May 1;33(2):143-158. PMCID: PMC8356637
Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E; MTN-020/ASPIRE Study Team. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa. BMC Womens Health 2021 Apr 23;21(1):175. PMCID: PMC8067655
Young A, Ryan J, Reddy K, Palanee-Phillips T, Chitukuta M, Mwenda W, Kemigisha D, Musara P, van der Straten A; MTN-041/MAMMA Study Team. Religious leaders' role in pregnant and breastfeeding women's decision making and willingness to use biomedical HIV prevention strategies: a multi-country analysis. Cult Health Sex 2021 Apr 2:1-16. Epub ahead of print.
Flax VL, Hawley I, Ryan J, Chitukuta M, Mathebula F, Nakalega R, Seyama L, Taulo F, van der Straten A; MTN-041/MAMMA Study Team. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa. Matern Child Nutr 2021 Apr;17(2):e13120. PMCID: PMC7988874
Naidoo K, Mansoor LE, Katz AW, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET. Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial. J Acquir Immune Defic Syndr 2021 Apr 1;86(4):e90-e96. PMCID: PMC7902420
Balkus JE, Neradilek M, Fairlie L, Makanani B, Mgodi N, Mhlanga F, Nakabiito C, Mayo A, Harrell T, Piper J, Bunge KE; MTN-042B Study Team. Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review. PLoS One 2021 Mar 31;16(3):e0248423. PMCID: PMC8011748
Wilson EK, Wagner LD, Palanee-Phillips T, Roberts ST, Tolley EE, Mathebula F, Pascoe L, Lanham M, Wilcher R, Montgomery ET; CHARISMA team. Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study. BMC Womens Health 2021 Mar 25;21(1):126. PMCID: PMC7992829.
Farr Zuend C, Noel-Romas L, Hoger S, Mccorriser S, Westmacott G, Marrazzo J, Hillier SL, Dezzutti C, Squires K, Bunge KE, Burgener A. Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls. AIDS 2021 Mar 1;35(3):369-380. PMCID: PMC7924934
Kutner BA, Giguere R, Lentz C, Kajura-Manyindo C, Dolezal C, Butheliezi S, Gwande M, Nampiira S, Ndlovu T, Mvinjelwa P, Mwenda W, Balán IC. Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV. AIDS Behav 2021 Mar;25(3):721-731. PMCID: PMC7887002
Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER; MTN-025/HOPE Study Team. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV 2021 Feb;8(2):e87-e95. PMCID: PMC8038210
Balán IC, Giguere R, Lentz C, Kutner, Kajura-Manyindo C, Byogero R, Biira Asiimwe F, Makala Y, Jambaya J, Khanyile N, Chetty D, Soto-Torres L, Mayo A, Mgodi NM, Palanee-Phillips T, Baeten JM and the MTN-025 (HOPE Study) Team. Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study). AIDS Behav 2021 Feb;25(2):447-458. PMCID: PMC7855635
Lentz C, Giguere R, Kutner B, Dolezal C, Kajura-Manyindo C, Yambira M, et al. Culturally-based challenges to and recommendations for delivering adherence counseling in a multicultural biomedical HIV prevention trial in four African countries. AIDS Educ Prev 2020 Dec;32(6):512-527. PMCID: PMC8059360
Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, Marzinke MA, Bekker LG, Soto-Torres L, Hillier SL, Baeten JM; MTN-020/ASPIRE Study Team. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc 2020 Nov;23(11):e25634. PMCID: PMC7673220
Giguere R, Lentz C, Kajura-Manyindo C, Kutner BA, Dolezal C, Buthelezi M, Lukas I, Nampiira S, Rushwaya C, Sitima E, Katz A, van der Straten A, Balán IC. Counselors' acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countries. AIDS Care 2020 Jan-Dec;32(sup1):19-28. PMCID: PMC7642092.
Brown ER, Dominguez Islas CP, Zhang J. Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials. Stat Commun Infect Dis September 24, 2020; 12(S1) Article 20190016
Balán IC, Lentz C, Giguere R, Mayo AJ, Rael CT, Soto-Torres L, Palanee-Phillips T, Mgodi NM, Hillier S, Baeten JM; MTN-025/HOPE Study Team. Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study. AIDS Care 2020;32(9):1082-1091. PMCID: PMC7332390
Moodley J, Naidoo S, Kelly C, Reddy T, Ramjee G. The Impact of Male Partner Circumcision on Women's Health Outcomes. AIDS Educ Prev. 2020;32(4):356-366. PMCID: PMC7585933
Manohar M, Marzinke MA. Validation and implementation of an ultrasensitive liquid chromatographic-tandem mass spectrometric (LC-MS/MS) assay for dapivirine quantitation in breast milk. Clin Biochem 2020;82:66-72. PMCID: PMC6944438
Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, Zimba C, Montgomery ET. The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav 2020;24(8):2387-2399.
Mishra A, Bůžková P, Balkus JE and Brown ER. Accounting for informative sampling in estimation of associations between sexually transmitted infections and hormonal contraceptive methods. Stat Commun Infect Dis July 5, 2020; 12(1) Article 20190010
van der Straten A, Ryan JH, Reddy K, et al. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study. J Int AIDS Soc 2020;23(6):e25536. PMCID: PMC7287313
Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET; for the MTN-020/ASPIRE Team. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial. AIDS Behav 2020 May;24(5):1432-1442. PMCID: PMC7162727
Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T; MTN-020/ASPIRE and MTN-003/VOICE Study Teams. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS 2020 Mar 15;34(4):559-567. PMCID: PMC7262458
Peebles K, van der Straten A, Palanee-Phillips T, Reddy K, Hillier SL, Hendrix CW, Harkoo I, Mirembe BG, Jeenarain N, Baeten JM, Brown ER. Brief Report: Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention. J Acquir Immune Defic Syndr 2020 Mar 1;83(3):197-201. PMCID: PMC7027377
Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET; MTN-020/ASPIRE Study Team. Relationship type and use of the vaginal ring for HIV-1 prevention in the MTN 020/ASPIRE trial. AIDS Behav 2020 Mar;24(3):866-880. PMCID: PMC6864230
Bunge KE, Levy L, Szydlo DW, Zhang J, Gaur AH, Reirden D, Mayer KH, Futterman D, Hoesley C, Hillier SL, Marzinke MA, Hendrix CW, Gorbach PM, Wilson CM, Soto-Torres L, Kapogiannis B, Nel A, Squires KE; MTN-023/IPM 030 Study Team. Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women. J Acquir Immune Defic Syndr 2020 Feb 1;83(2):135-139. PMCID: PMC8577288